AllergoOncology: IgE- and IgG4-mediated immune mechanisms linking allergy with cancer and their translational implications

Journal of Allergy and Clinical Immunology

Volumn 140, Issue 4, 2017, Pages 982-984

  Jensen Jarolim, Erika ^a,b   Turner, Michelle C ^c,d,e,f   Karagiannis, Sophia N ^g,h  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f UNIVERSITY OF OTTAWA   (Canada)

^g ST THOMAS HOSPITAL   (United Kingdom)

^h GUY S HOSPITAL   (United Kingdom)

Author keywords

AllergoOncology; Allergy; antibody dependent cell mediated cytotoxicity; cancer; clinical oncology; effector cells; IgE; oncoimmunology; tolerance; tumor

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN G;

ALLERGY; ATOPY; CANCER EPIDEMIOLOGY; EDITORIAL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MALIGNANT NEOPLASM; PRIORITY JOURNAL; ANIMAL; HYPERSENSITIVITY; IMMUNOLOGY; NEOPLASM;

ANIMALS; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; NEOPLASMS;

EID: 85020644894     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2017.04.034     Document Type: Editorial

References (18)

1. Jensen-Jarolim, E., Achatz, G., Turner, M.C., Karagiannis, S., Legrand, F., Capron, M., et al. AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy 63 (2008), 1255–1266.
2. Jensen-Jarolim, E., Bax, H.J., Bianchini, R., Capron, M., Corrigan, C., Castells, M., et al. AllergoOncology—the impact of allergy in oncology: EAACI position paper. Allergy 72 (2017), 866–887.
3. Amirian, E.S., Zhou, R., Wrensch, M.R., Olson, S.H., Scheurer, M.E., Il'yasova, D., et al. Approaching a scientific consensus on the association between allergies and glioma risk: a report from the Glioma International Case-Control Study. Cancer Epidemiol Biomarkers Prev 25 (2016), 282–290.
4. Schwartzbaum, J., Seweryn, M., Holloman, C., Harris, R., Handelman, S.K., Rempala, G.A., et al. Association between prediagnostic allergy-related serum cytokines and glioma. PLoS One, 10, 2015, e0137503.
5. Wulaningsih, W., Holmberg, L., Garmo, H., Karagiannis, S.N., Ahlstedt, S., Malmstrom, H., et al. Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival. Oncoimmunology, 5, 2016, e1154250.
6. Mohr, A., Renaudineau, Y., Bagacean, C., Pers, J.O., Jamin, C., Bordron, A., Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia. Oncoimmunology, 5, 2016, e1132977.
7. Stanic, B., van de Veen, W., Wirz, O.F., Ruckert, B., Morita, H., Sollner, S., et al. IL-10-overexpressing B cells regulate innate and adaptive immune responses. J Allergy Clin Immunol 135 (2015), 771–780.e8.
8. van de Veen, W., Stanic, B., Wirz, O.F., Jansen, K., Globinska, A., Akdis, M., Role of regulatory B cells in immune tolerance to allergens and beyond. J Allergy Clin Immunol 138 (2016), 654–665.
9. Davies, A.M., Sutton, B.J., Human IgG4: a structural perspective. Immunol Rev 268 (2015), 139–159.
10. Pali-Scholl, I., Jensen-Jarolim, E., The concept of allergen-associated molecular patterns (AAMP). Curr Opin Immunol 42 (2016), 113–118.
11. Jensen-Jarolim, E., Roth-Walter, F., Pacios, L., Wagner, S., Glenk, L., Hofstetter, G., et al. IgG4 drives M2 macrophages to cortisol, Lcn-2 and IL-10 release: implications in maintenance of tolerance and allergen immunotherapy. Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI). J Allergy Clin Immunol, 137(suppl), 2016 AB403, L43.
12. Karagiannis, P., Villanova, F., Josephs, D.H., Correa, I., Van Hemelrijck, M., Hobbs, C., et al. Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma. Oncoimmunology, 4, 2015, e1032492.
13. Wallace, Z.S., Wallace, C.J., Lu, N., Choi, H.K., Stone, J.H., Association of IgG4-related disease with history of malignancy. Arthritis Rheumatol 68 (2016), 2283–2289.
14. Asano, J., Watanabe, T., Oguchi, T., Kanai, K., Maruyama, M., Ito, T., et al. Association between immunoglobulin G4-related disease and malignancy within 12 years after diagnosis: an analysis after longterm followup. J Rheumatol 42 (2015), 2135–2142.
15. Karagiannis, P., Gilbert, A.E., Josephs, D.H., Ali, N., Dodev, T., Saul, L., et al. IgG4 subclass antibodies impair antitumor immunity in melanoma. J Clin Invest 123 (2013), 1457–1474.
16. Zennaro, D., Capalbo, C., Scala, E., Liso, M., Spillner, E., Penichet, M., et al. IgE, IgG4 and IgG response to tissue-specific and environmental antigens in patients affected by cancer. Annual Meeting of the European Academy of Allergy and Clinical Immunology. 2011, Allergy, Istanbul 66:100.
17. Crescioli, S., Correa, I., Karagiannis, P., Davies, A.M., Sutton, B.J., Nestle, F.O., et al. IgG4 Characteristics and Functions in Cancer Immunity. Curr Allergy Asthma Rep, 16, 2016, 7.
18. Renand, A., Archila, L.D., McGinty, J., Wambre, E., Robinson, D., Hales, B.J., et al. Chronic cat allergen exposure induces a TH2 cell-dependent IgG4 response related to low sensitization. J Allergy Clin Immunol 136 (2015), 1627–1635 e1-13.